Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial.
clinical trial
mobile application
mobile phone
primary public health
tobacco smoking
tobacco use cessation
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
26 06 2020
26 06 2020
Historique:
received:
09
09
2019
accepted:
29
03
2020
revised:
09
12
2019
entrez:
27
6
2020
pubmed:
27
6
2020
medline:
28
4
2021
Statut:
epublish
Résumé
Mobile apps provide an accessible way to test new health-related methodologies. Tobacco is still the primary preventable cause of death in industrialized countries, constituting an important public health issue. New technologies provide novel opportunities that are effective in the cessation of smoking tobacco. This paper aims to evaluate the efficacy and usage of a mobile app for assisting adult smokers to quit smoking. We conducted a cluster randomized clinical trial. We included smokers older than 18 years who were motivated to stop smoking and used a mobile phone compatible with our mobile app. We carried out follow-up visits at 15, 30, and 45 days, and at 2, 3, 6, and 12 months. Participants of the intervention group had access to the Tobbstop mobile app designed by the research team. The primary outcomes were continuous smoking abstinence at 3 and 12 months. A total of 773 participants were included in the trial, of which 602 (77.9%) began the study on their D-Day. Of participants in the intervention group, 34.15% (97/284) did not use the app. The continuous abstention level was significantly larger in the intervention group participants who used the app than in those who did not use the app at both 3 months (72/187, 38.5% vs 13/97, 13.4%; P<.001) and 12 months (39/187, 20.9% vs 8/97, 8.25%; P=.01). Participants in the intervention group who used the app regularly and correctly had a higher probability of not being smokers at 12 months (OR 7.20, 95% CI 2.14-24.20; P=.001) than the participants of the CG. Regular use of an app for smoking cessation is effective in comparison with standard clinical practice. Clinicaltrials.gov NCT01734421; https://clinicaltrials.gov/ct2/show/NCT01734421.
Sections du résumé
BACKGROUND
Mobile apps provide an accessible way to test new health-related methodologies. Tobacco is still the primary preventable cause of death in industrialized countries, constituting an important public health issue. New technologies provide novel opportunities that are effective in the cessation of smoking tobacco.
OBJECTIVE
This paper aims to evaluate the efficacy and usage of a mobile app for assisting adult smokers to quit smoking.
METHODS
We conducted a cluster randomized clinical trial. We included smokers older than 18 years who were motivated to stop smoking and used a mobile phone compatible with our mobile app. We carried out follow-up visits at 15, 30, and 45 days, and at 2, 3, 6, and 12 months. Participants of the intervention group had access to the Tobbstop mobile app designed by the research team. The primary outcomes were continuous smoking abstinence at 3 and 12 months.
RESULTS
A total of 773 participants were included in the trial, of which 602 (77.9%) began the study on their D-Day. Of participants in the intervention group, 34.15% (97/284) did not use the app. The continuous abstention level was significantly larger in the intervention group participants who used the app than in those who did not use the app at both 3 months (72/187, 38.5% vs 13/97, 13.4%; P<.001) and 12 months (39/187, 20.9% vs 8/97, 8.25%; P=.01). Participants in the intervention group who used the app regularly and correctly had a higher probability of not being smokers at 12 months (OR 7.20, 95% CI 2.14-24.20; P=.001) than the participants of the CG.
CONCLUSIONS
Regular use of an app for smoking cessation is effective in comparison with standard clinical practice.
TRIAL REGISTRATION
Clinicaltrials.gov NCT01734421; https://clinicaltrials.gov/ct2/show/NCT01734421.
Identifiants
pubmed: 32589153
pii: v8i6e15951
doi: 10.2196/15951
pmc: PMC7381259
doi:
Banques de données
ClinicalTrials.gov
['NCT01734421']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15951Informations de copyright
©Meritxell Pallejà-Millán, Cristina Rey-Reñones, Maria Luisa Barrera Uriarte, Esther Granado-Font, Josep Basora, Gemma Flores-Mateo, Jordi Duch. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 26.06.2020.
Références
J Med Internet Res. 2016 May 16;18(5):e97
pubmed: 27185295
BMC Public Health. 2013 Aug 01;13:704
pubmed: 23915067
Lancet. 2015 Mar 14;385(9972):966-76
pubmed: 25784347
Am J Public Health. 2014 Dec;104(12):e72-6
pubmed: 25320891
Transl Behav Med. 2020 Feb 3;10(1):302-309
pubmed: 30476293
JMIR Mhealth Uhealth. 2019 Apr 25;7(4):e12482
pubmed: 31021326
Nicotine Tob Res. 2018 Nov 15;20(12):1507-1514
pubmed: 29065202
Transl Behav Med. 2017 Jun;7(2):292-299
pubmed: 28527027
Cochrane Database Syst Rev. 2012 Nov 14;11:CD006611
pubmed: 23152238
JMIR Mhealth Uhealth. 2019 Mar 07;7(3):e10750
pubmed: 30843864
JMIR Serious Games. 2019 Mar 27;7(1):e12835
pubmed: 30916655
Aust N Z J Public Health. 2017 Dec;41(6):625-630
pubmed: 28749591
J Pers Med. 2014 Jul 18;4(3):412-23
pubmed: 25563359
J Med Internet Res. 2019 Mar 19;21(3):e12053
pubmed: 30888321
Psychol Rep. 1998 Dec;83(3 Pt 2):1455-8
pubmed: 10079737
BMJ Open. 2018 Jan 21;8(1):e017105
pubmed: 29358418
J Med Internet Res. 2017 Apr 19;19(4):e125
pubmed: 28428170
JMIR Mhealth Uhealth. 2014 May 07;2(2):e23
pubmed: 25099632
J Med Internet Res. 2015 Nov 10;17(11):e253
pubmed: 26554314
J Med Internet Res. 2015 Jan 16;17(1):e17
pubmed: 25596170
Addiction. 1993 Aug;88(8):1127-35
pubmed: 8401167
PLoS One. 2018 Jul 26;13(7):e0201166
pubmed: 30048546
Cochrane Database Syst Rev. 2019 Oct 22;10:CD006611
pubmed: 31638271
JMIR Mhealth Uhealth. 2017 Apr 25;5(4):e56
pubmed: 28442453